Sponsor pipeline

Chengdu JOYO pharma Co., Ltd. clinical trial pipeline

Get alerts when Chengdu JOYO pharma Co., Ltd.'s trials change

2 active trials 1 recruiting 1 Phase 3 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

First postedNew trial filingPhaseStatus
2026-08-25 NCT07784036 JYP0035 Capsules Plus Fulvestrant in PIK3CA-Mutant HR+/HER2- Advanced Breast Cancer Phase 3 Not Yet Recruiting

Active trials by phase

Phase 1
1
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07784036 JYP0035 Capsules Plus Fulvestrant in PIK3CA-Mutant HR+/HER2- Advanced Breast Cancer Breast Cancer Not Yet Recruiting 2026-08-25
Phase 1
NCT06158477 A Clinical Trial Evaluating JYP0035 Capsule Monotherapy in Patients With Advanced Solid… Advanced Solid Tumors Recruiting 2024-11-18

Disease areas by active trials

Get alerts when Chengdu JOYO pharma Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free